Shares of Becton Dickinson & Co. BDX inched 0.36% higher to $238.22 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.90% to ...
Evercore ISI analyst Vijay Kumar raised the firm’s price target on Becton Dickinson (BDX) to $290 from $286 and keeps an ...
BD (Becton, Dickinson and Company) (BDX) announced an agreement to resolve the majority of its ongoing hernia litigation. The ...
Becton Dickinson & Co. closed $32.25 short of its 52-week high ($269.52), which the company reached on October 10th.
SIPTU workers at the Becton Dickinson manufacturing plant in Drogheda placed a picket at the entrance to the plant at ...
Medical device manafacturer BD (Becton Dickinson) is to refer a dispute over severance packages at its Drogheda plant to the ...
MedTech is a promising market driven by rising disease prevalence, innovative healthcare solutions, and significant growth in ...
Katie Szyman, who led Edwards Lifesciences Corp.’s Critical Care unit that was recently sold for $4.2 billion, says ...